KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Equity Ratio (2020 - 2025)

Organon has reported Equity Ratio over the past 6 years, most recently at 0.06 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.06 for Q4 2025, up 62.22% from a year ago — trailing twelve months through Dec 2025 was 0.06 (up 62.22% YoY), and the annual figure for FY2025 was 0.06, up 62.22%.
  • Equity Ratio for Q4 2025 was 0.06 at Organon, down from 0.07 in the prior quarter.
  • Over the last five years, Equity Ratio for OGN hit a ceiling of 0.49 in Q1 2021 and a floor of 0.18 in Q2 2021.
  • Median Equity Ratio over the past 5 years was 0.03 (2023), compared with a mean of 0.01.
  • Biggest five-year swings in Equity Ratio: crashed 126.02% in 2021 and later soared 920.59% in 2025.
  • Organon's Equity Ratio stood at 0.14 in 2021, then soared by 42.33% to 0.08 in 2022, then skyrocketed by 92.87% to 0.01 in 2023, then skyrocketed by 720.6% to 0.04 in 2024, then skyrocketed by 62.22% to 0.06 in 2025.
  • The last three reported values for Equity Ratio were 0.06 (Q4 2025), 0.07 (Q3 2025), and 0.05 (Q2 2025) per Business Quant data.